The nature of information required in making an application for the R&D tax incentive has been kept to a minimum. The information required is in two parts, firstly is the specific administrative information that assists in identifying the company, contact details, and the agent involved in making the application, etc. Secondly is the information on the R&D activities that assists in determining eligibility of the intended activities.

With respect to R&D activities, the following is required:

  • To indicate under which subsection(s) an application is made. Whether  it is for the:

o   Discovery of non-obvious S&T knowledge;

o   Creating or developing an invention, functional design, computer program, multisource pharmaceutical product(s) or knowledge essential to their usage;

o   Making significant improvements to any of the abovementioned aspects; or

o   Conducting a clinical trial.

  • To give a description of the systematic investigative or systematic experimental (SIE) activities being undertaken (in order to achieve what is indicated above). To be considered R&D, outcomes of such activities must be uncertain, i.e. non-obvious.
  • To describe how the intended activities will advance the existing base of scientific and technological knowledge in the relevant field.
  • With respect to the ‘significant and innovative improvement’, the application must further describe the innovative aspects involved compared to the existing base in order to explain the scientific or technological advancements.